On August 14, 2015, a motion for authority to sell assets of the estates pursuant to section 363 of the Bankruptcy Code was filed in the bankruptcy case of Response Genetics, Inc. (f/d/b/a Bio Type, Inc.) and its affiliates.
The filing was assigned docket number 39 and is described on the court’s official docket as follows:
Motion For Sale of Property Free and Clear of Liens under Section 363(f)(FEE) /Debtor’s Motion for Order (A) Approving Asset Purchase Agreement and Authorizing the Sale of Substantially All of the Debtor’s Assets; (B) Authorizing the Sale of Assets Free and Clear of All Liens, Claims, Rights, Encumbrances and Other Interests Pursuant to Bankruptcy Code Sections 105, 363(b), 363(f) and 363(m); (C) Assuming and Assigning Certain Executory Contracts and Unexpired Leases; and (D) Granting Related Relief Fee Amount $176 Filed by Response Genetics, Inc.. (Attachments: # (1) Exhibit A – Asset Purchase Agreement # (2) Exhibit B – Proposed Order) (O’Neill, James)
Response Genetics, Inc. (f/d/b/a Bio Type, Inc.) filed for bankruptcy protection, or had an involuntary bankruptcy petition filed against it, on August 9, 2015. The bankruptcy case is pending before the United States Bankruptcy Court for the District of Delaware. The case number for the lead bankruptcy case is 15-11663. The bankruptcy case is currently assigned to United States Bankruptcy Judge Laurie Selber Silverstein. The law firm of Pachulski Stang Ziehl & Jones LLP is acting as lead bankruptcy counsel to Response Genetics, Inc. (f/d/b/a Bio Type, Inc.) in the bankruptcy case.